Abstract
Background The COVID-19 pandemic necessitated major re-allocation of health care services. Our aim was to assess the impact on paediatric congenital heart disease procedures during different pandemic periods compared to the pre-pandemic period, to inform appropriate responses to future major health services disruptions.
Methods and Results We analysed 26,270 procedures from 17,860 children between 01-Jan-2018 and 31-Mar-2022 in England, linking them to primary/secondary care data. The study period included pre-pandemic and pandemic phases, with latter including three restriction periods and corresponding relaxation periods. We compared procedure characteristics and outcomes between each pandemic periods and the pre-pandemic period. There was a reduction in all procedures across all pandemic period with the largest reductions during the first, most severe restriction period (23-Mar-2020 to 23-Jun-2020), and the relaxation period following second restrictions (03-Dec-2020 to 04-Jan-2021) coinciding with winter pressures. During the first restrictions, median procedures per week dropped by 51 compared with the pre-pandemic period(80 vs 131 per week, p = 4.98×10-08). Elective procedures drove these reductions, falling from 96 to 44 per week, (p = 1.89×10-06), while urgent (28 vs 27 per week, p = 0.649) and life-saving/emergency procedures (7 vs 6 per week, p = 0.198) remained unchanged. Cardiac surgery rates increased, and catheter-based procedure rates reduced during the pandemic. Procedures for children under 1-year were prioritized, especially during the first four pandemic periods. No evidence was found for differences in post procedure complications (age adjusted odds ratio 1.1 (95%CI: 0.9, 1.4) or post procedure mortality (age and case mix adjusted odds ratio 0.9 (0.6, 1.3)).
Conclusions Prioritization of urgent, emergency and life-saving procedures during the pandemic, particularly in infants, did not impact paediatric CHD post procedure complications or mortality. This information is valuable for future major health services disruptions, though longer-term follow-up of the effects of delaying elective surgery is needed.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://github.com/BHFDSC/CCU007_01/Protocol
Funding Statement
The British Heart Foundation Data Science Centre (grant No SP/19/3/34678, awarded to Health Data Research (HDR) UK) funded co-development (with NHS England) of the Secure Data Environment service for England, provision of linked datasets, data access, user software licences, computational usage, and data management and wrangling support, with additional contributions from the HDR UK Data and Connectivity component of the UK Government Chief Scientific Adviser National Core Studies program to coordinate national COVID-19 priority research. Consortium partner organizations funded the time of contributing data analysts, biostatisticians, epidemiologists, and clinicians. This study was funded by the British Heart Foundation (AA/18/1/34219) and Bristol National Institute for Health Research Biomedical Research Centre. GA (R104281-102) MC(CH/17/1/32804) and DAL(CH/F/20/90003) contributions are supported by their British Heart Foundation Chairs. AKS and DAL contribution is further supported by DAL National Institute for Health Research Senior Investigator Award ((NF-0616-10102). AKS, VW, and DAL work in, or are affiliated with, the UK Medical Research Council Integrative Epidemiology Unit (MC_UU_00032/03 and MC_UU_00032/05). RD and VW received support from the Longitudinal Health and Wellbeing COVID-19 National Core Study, which was established by the UK Chief Scientific Officer in October 2020 and funded by UK Research and Innovation (grant references MC_PC_20030 and MC_PC_20059) and from the CONVALESCENCE study of long COVID-19 funded by National Institute for Health and Care Research (NIHR)/UK Research and Innovation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The North East - Newcastle and North Tyneside 2 research ethics committee provided ethical approval for the CVD-COVID-UK/COVID-IMPACT research programme (REC No 20/NE/0161)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Reduced word count for the main text. Moved additional methods to Supplementary text. Supplementary files updated
Data Availability
The data used in this study are available in NHS England Secure Data Environment service for England, but as restrictions apply they are not publicly available. Those wishing to gain access to the data should contact British Heart Foundation Data Science Centre in the first instance.
https://digital.nhs.uk/services/secure-data-environment-service
